Yes, and by more than most people expect. In studies of adults with knee osteoarthritis, losing around ten percent of body weight produced meaningful reductions in pain and clear improvements in function. For someone at 240 pounds, that is 24 pounds. A medical program adds the appetite-regulating medications semaglutide and tirzepatide, and physician supervision, to make that loss achievable for someone whose pain makes exercise hard.
What extra weight does to a joint
The knee is the clearest example. When you walk, the force through each knee is several times your body weight because of the leverage of the leg. The commonly quoted research figure is that every extra pound of body weight adds about four pounds of load across the knee with each step. Twenty extra pounds is 80 extra pounds on the joint, thousands of times a day. Over years that accelerates the cartilage wear that becomes osteoarthritis, and once arthritis is there, the load makes every step hurt more.
The hips carry a similar burden. The lower back is different and no better off: weight around the middle pulls the pelvis forward, increases the curve of the lower spine, and loads the discs and the small facet joints that are the usual sources of chronic back pain.
The inflammation problem
Load is only part of it. Fat tissue produces inflammatory chemicals that circulate through the body and make joints and nerves more sensitive to pain. This is why people carrying extra weight also report more pain in joints that carry no load, such as the hands, and it is part of why weight loss reduces pain by more than the mechanical numbers alone would predict.
The cycle
The same pattern comes up again and again. Pain makes walking unpleasant, so a person walks less. Less walking means weaker muscles around the knee and spine, so the joints get less support and hurt more. It also means fewer calories burned, often more eating for comfort, and rising weight, which means more load and more inflammation. Every step in the loop is understandable and none of it is a personal failing. Willpower alone rarely reverses it, because the pain is a real barrier and appetite is regulated by hormones that diets do not touch.
How much weight loss makes a difference
Less than most people assume. The ten percent figure above comes from knee osteoarthritis studies, and larger losses produced larger improvements, but the first ten percent already changes how a joint feels. For back pain the evidence is less precise, and the same pattern holds in practice: patients who lose weight report fewer flare-ups and better tolerance for the activities that used to trigger them.
What a medical program adds
The difference between a medical weight loss program and another diet is the medication and the supervision. Semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro) act on the hormones that control appetite. They slow stomach emptying and signal fullness to the brain, so eating less stops being a constant effort. In clinical trials adults lost an average of around 15 percent of body weight on semaglutide and around 20 percent on the higher doses of tirzepatide over roughly a year and a half. Results vary from person to person.
The medication is a once-weekly injection you give yourself at home. A physician prescribes it after a consultation and labs, increases the dose every few weeks as you tolerate it, and sees you monthly. Alongside it you get plain guidance on eating enough protein to protect muscle and on activity your joints can cope with, which often means walking in a pool or on flat ground before anything more.
For a pain patient this is part of pain treatment. As weight comes off, injections work better, medication doses can come down, and activity becomes possible again, which strengthens the muscles that protect the joint. Our medical weight loss page covers the program, eligibility and safety in detail, and the semaglutide and tirzepatide pages cover each medication.
Who it suits
The program is for adults with a BMI of 30 or more, or 27 or more with a weight-related condition, and osteoarthritis counts. It is not for people with a personal or family history of medullary thyroid cancer, anyone who is pregnant or planning to be, or anyone with a history of pancreatitis. Insurance coverage for the medication varies widely. Our front desk checks your plan before the visit and explains the self-pay option if it is not covered.
The first step is a conversation
At AffordaHealth in Davie and Boynton Beach, weight loss sits inside a pain practice, so the team treating your knee or back is the same team supervising your medication. There is no commitment at the first visit. You come in, we talk about your health, your pain and what you are hoping for, and we tell you whether this is a good fit. Book an appointment online, or call either clinic.
Questions patients ask
How much weight do I need to lose to help my knees?
Around ten percent of body weight is the point at which knee osteoarthritis studies show meaningful pain reduction and better function. Larger losses help more, and the first ten percent already changes how the joint feels.
Does insurance cover semaglutide or tirzepatide for weight loss?
Coverage varies widely between plans. The front desk at AffordaHealth checks your specific plan before your visit and explains the self-pay option if the medication is not covered. Consultations and labs are covered by Medicare, Aetna, Blue Cross Blue Shield and Cigna.
Can I start a weight loss program if I have arthritis and can barely walk?
Yes. The program is built for exactly that situation. The medication reduces appetite so weight loss does not depend on exercise you cannot do, and activity is introduced at a level your joints can cope with, such as walking in a pool.
Who is not eligible?
People with a personal or family history of medullary thyroid cancer, anyone who is pregnant or planning pregnancy, and anyone with a history of pancreatitis. The physician reviews your history and labs at the first visit before prescribing.